Processing

Please wait...

Settings

Settings

Goto Application

1. WO2020092193 - TREATMENTS FOR ZIKA VIRUS INFECTION

Publication Number WO/2020/092193
Publication Date 07.05.2020
International Application No. PCT/US2019/058263
International Filing Date 28.10.2019
IPC
A61K 31/138 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
13Amines, e.g. amantadine
135having aromatic rings, e.g. methadone
138Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
A61K 31/135 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
13Amines, e.g. amantadine
135having aromatic rings, e.g. methadone
A61P 31/12 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
31Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
12Antivirals
A61P 31/14 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
31Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
12Antivirals
14for RNA viruses
Applicants
  • SAINT LOUIS UNIVERSITY [US]/[US]
Inventors
  • ARNATT, Christopher
  • BRIEN, James
  • PINTO, Amelia
Agents
  • HIGHLANDER, Steven, L.
Priority Data
62/754,71102.11.2018US
Publication Language English (EN)
Filing Language English (EN)
Designated States
Title
(EN) TREATMENTS FOR ZIKA VIRUS INFECTION
(FR) TRAITEMENTS D'UNE INFECTION PAR LE VIRUS ZIKA
Abstract
(EN)
The present disclosure is directed to methods of treating Zika virus infections using selective estrogen receptor modulators (SERMs), such as Tamoxifen, or a compound selected from CALP-l, A7, PMA, Chelerythrine, PHTPP, Tariquidar or S-Equol.
(FR)
La présente invention concerne des méthodes de traitement d'infections par le virus Zika faisant appel à des modulateurs sélectifs du récepteur des œstrogènes (SERM), tels que le tamoxifène, ou un composé choisi parmi les CALP-l, A7, PMA, Chélérythrine, PHTPP, Tariquidar ou S-Équol.
Latest bibliographic data on file with the International Bureau